Skip to main content
. 2015 Apr 15;11(4):433–444. doi: 10.5664/jcsm.4600

Figure 3. Comparisons of AHI for PM before PSG (P1), PM simultaneous with PSG (P2) and PM after PSG (P3) for Group 1 subjects (N = 52).

Figure 3

(A) P1 versus P2 (r = 0.80, p = 0.14). (B) P3 versus P2 (r = 0.87, p = 0.63). (C) P1 versus P3, (r = 0.84, p = 0.26).

HHS Vulnerability Disclosure